Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Elixinol Global.
RELATED STOCKHEAD STORIES
Health & Biotech
Elixinol raises another $50m, bringing its total fundraising to $120m in 18 months
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
News
IG Markets looked at almost 1000 pot stocks before deciding to ban 19
Health & Biotech
A third of US CBD companies are ‘about to disappear’ – and that’s great news
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
News
Quarterlies: Elixinol revenue slides as cash burn jumps nearly 290pc
News
Weed Week: Has pot *really* gone from Pineapple Express to luxury status symbol?
News
Women are naturally drawn to medical marijuana, says Elixinol Global MD
Food & Agriculture
Weed Week: How do you compete in the US? Money and Martha Stewart
Food & Agriculture
The Pot Seat: Elixinol’s Paul Benhaim is spending to stay on top
Food & Agriculture
Hemp grower Elixinol is still making $$$: revenue doubles, loss decimated
Health & Biotech
The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs
Health & Biotech
Weed week: In Canada pot is hot; in Australia it’s just a steady glow
Health & Biotech
If pot is so hot, why aren’t cannabis directors buying their own companies?
Health & Biotech
Profitable pot stock Elixinol is getting excited about US growth opportunities
Health & Biotech
Nearly every country in the world is better at pot than Australia: Elixinol boss
News